Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

Reducing <i>Clostridium Difficile</i> Infection Rates
Panelists highlight additional considerations in the treatment and management of Clostridium difficile infection.
<i>Pseudomonas</i> Infections: Matching Causes and Prevention
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Marin Hristos Kollef, MD; Andrew Shorr, MD; and Yoav Golan, MD, differentiate between pseudomonas colonization and infection, discussing important prevention methods regarding the causes of affliction.
Gram-Negative NIs: Vabomere and the TANGO II Study
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; and Andrew Shorr, MD, discuss the recent approval of Vabomere, a combination of meropenem and vaborbactam, in the setting of gram-negative nosocomial infections based on the positive study results of the TANGO II trial.
<i>Clostridium Difficile</i>: Avoiding High-Risk Antibiotics
Following in-depth discussions regarding the risk for developing Clostridium difficile with the use of certain antibiotic therapies, Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, suggest how antimicrobial stewardship can improve patient outcomes.
Diagnostic Tests for Gram-Negative Nosocomial Infections
Panelists provide their perspectives on which tests are most important in identifying a gram-negative nosocomial infection and which approaches are necessary to optimize this stratification.
<i>Pseudomonas</i> Infections in the ICU: Who's Susceptible?
Peter L. Salgo, MD; Marin Hristos Kollef, MD; Jason Pogue, PharmD, BCPS-AQID; Yoav Golan, MD; and Andrew Shorr, MD, identify which patients are most susceptible to Pseudomonas infections and address the settings in which risk for infection is greatest.
<i>C. difficile</i> Rates in the United Kingdom
Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.
Fecal Transplantation in <i>Clostridium difficile</i>
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, consider variables surrounding the use of fecal transplantation for the management of Clostridium difficile in select groups of patients.
FEATURED
Big advances in treatment can